Mutations of the presenilin I gene in families with early-onset Alzheimer's disease D Campion, JM Flaman, A Brice, D Hannequin, B Dubois, C Martin, ... Human molecular genetics 4 (12), 2373-2377, 1995 | 359 | 1995 |
Antioxidant and anti-inflammatory properties of a Cucumis melo LC. extract rich in superoxide dismutase activity I Vouldoukis, D Lacan, C Kamate, P Coste, A Calenda, D Mazier, M Conti, ... Journal of Ethnopharmacology 94 (1), 67-75, 2004 | 283 | 2004 |
Microbial antioxidant defense enzymes C Staerck, A Gastebois, P Vandeputte, A Calenda, G Larcher, L Gillmann, ... Microbial Pathogenesis 110, 56-65, 2017 | 237 | 2017 |
Supplementation with gliadin‐combined plant superoxide dismutase extract promotes antioxidant defences and protects against oxidative stress I Vouldoukis, M Conti, P Krauss, C Kamaté, S Blazquez, M Tefit, D Mazier, ... Phytotherapy Research 18 (12), 957-962, 2004 | 129 | 2004 |
The meiosis‐specific Xmr gene product is homologous to the lymphocyte Xlr protein and is a component of the XY body. A Calenda, B Allenet, D Escalier, JF Bach, HJ Garchon The EMBO Journal 13 (1), 100-109, 1994 | 92 | 1994 |
Geosmithia argillacea: an Emerging Pathogen in Patients with Cystic Fibrosis S Giraud, M Pihet, B Razafimandimby, J Carrere, N Degand, L Mely, ... Journal of clinical microbiology 48 (7), 2381-2386, 2010 | 77 | 2010 |
Leukotriene B4 potentiates the expression and release of Fc epsilon RII/CD23, and proliferation and differentiation of human B lymphocytes induced by IL-4. B Dugas, N Paul-Eugene, J Cairns, J Gordon, A Calenda, ... Journal of immunology (Baltimore, Md.: 1950) 145 (10), 3406-3411, 1990 | 69 | 1990 |
Genetic and physical analyses of the centromeric and pericentromeric regions of human chromosome 5: recombination across 5cen J Puechberty, AM Laurent, S Gimenez, A Billault, ME Brun-Laurent, ... Genomics 56 (3), 274-287, 1999 | 67 | 1999 |
A large pedigree with early-onset Alzheimer's disease: clinical, neuropathologic, and genetic characterization D Campion, A Brice, D Hannequin, S Tardieu, B Dubois, A Calenda, ... Neurology 45 (1), 80-85, 1995 | 66 | 1995 |
Immunohistochemical analysis of cerebral cortical and vascular lesions in the primate Microcebus murinus reveal distinct amyloid β1–42 and β1–40 immunoreactivity profiles N Mestre-Francés, E Keller, A Calenda, H Barelli, F Checler, N Bons Neurobiology of disease 7 (1), 1-8, 2000 | 63 | 2000 |
β-Amyloid protein precursor inmicrocebus murinus: genotyping and brain localization S Silhol, A Calenda, V Jallageas, N Mestre-Frances, M Bellis, N Bons Neurobiology of Disease 3 (3), 169-182, 1996 | 50 | 1996 |
Oxidative stress response pathways in fungi H Yaakoub, S Mina, A Calenda, JP Bouchara, N Papon Cellular and Molecular Life Sciences 79 (6), 333, 2022 | 47 | 2022 |
Role of nitric oxide in the anti-tumoral effect of retinoic acid and 1, 25-dihydroxyvitamin D3 on human promonocytic leukemic cells N Dugas, MD Mossalayi, A Calenda, A Leotard, P Becherel, F Mentz, ... | 46 | 1996 |
Activation and infection of B cells by Epstein-Barr virus. Role of calcium mobilization and of protein kinase C translocation. B Dugas, JF Delfraissy, A Calenda, M Peuchmaur, C Wallon, MT Rannou, ... Journal of immunology (Baltimore, Md.: 1950) 141 (12), 4344-4351, 1988 | 42 | 1988 |
Fc-receptor-mediated intracellular delivery of Cu/Zn-superoxide dismutase (SOD1) protects against redox-induced apoptosis through a nitric oxide dependent mechanism I Vouldoukis, V Sivan, MC Vozenin, C Kamaté, A Calenda, D Mazier, ... Molecular Medicine 6, 1042-1053, 2000 | 39 | 2000 |
Functional interaction between β2-adrenoceptor agonists and interleukin-4 in the regulation of CD23 expression and release and IgE production in human N Paul-Eugene, JP Kolb, A Calenda, J Gordon, K Hitoshi, K Tadamidsu, ... Molecular immunology 30 (2), 157-164, 1993 | 36 | 1993 |
Enzymatic mechanisms involved in evasion of fungi to the oxidative stress: focus on Scedosporium apiospermum C Staerck, P Vandeputte, A Gastebois, A Calenda, S Giraud, N Papon, ... Mycopathologia 183 (1), 227-239, 2018 | 31 | 2018 |
No founder effect in three novel Alzheimer's disease families with APP 717 Val--> Ile mutation. Clerget-darpoux. French Alzheimer's Disease Study Group. D Campion, A Brice, D Hannequin, F Charbonnier, B Dubois, C Martin, ... Journal of medical genetics 33 (8), 661-664, 1996 | 29 | 1996 |
The high osmolarity glycerol (HOG) pathway in fungi† H Yaakoub, NS Sanchez, L Ongay-Larios, V Courdavault, A Calenda, ... Critical Reviews in Microbiology 48 (6), 657-695, 2022 | 28 | 2022 |
Molecular Cloning, Sequencing, and Brain Expression of the Presenilin 1 Gene inMicrocebus murinus A Calenda, N Mestre-Francés, C Czech, L Pradier, A Petter, N Bons, ... Biochemical and biophysical research communications 228 (2), 430-439, 1996 | 26 | 1996 |